Grafton DBM
-
Biologics
Medtronic Announces Approval and Launch of Japan’s First DBM Bone Grafting Product for Spine and Orthopedic Procedures
DUBLIN and TOKYO – February 28, 2019 – Medtronic plc (NYSE:MDT) announced today the Japanese launch of the Grafton(TM) Demineralized Bone…
Read More »